Lv, F.;                     Jiang, Y.;                     Wang, Y.;                     Zhang, T.;                     Zhou, Y.    
        AGTR1rs5186 Polymorphism Is Associated with the Risk of Restenosis after Percutaneous Coronary Intervention: A Meta-Analysis. J. Cardiovasc. Dev. Dis. 2022, 9, 406.
    https://doi.org/10.3390/jcdd9110406
    AMA Style
    
                                Lv F,                                 Jiang Y,                                 Wang Y,                                 Zhang T,                                 Zhou Y.        
                AGTR1rs5186 Polymorphism Is Associated with the Risk of Restenosis after Percutaneous Coronary Intervention: A Meta-Analysis. Journal of Cardiovascular Development and Disease. 2022; 9(11):406.
        https://doi.org/10.3390/jcdd9110406
    
    Chicago/Turabian Style
    
                                Lv, Feng,                                 Yufeng Jiang,                                 Yebao Wang,                                 Ting Zhang,                                 and Yafeng Zhou.        
                2022. "AGTR1rs5186 Polymorphism Is Associated with the Risk of Restenosis after Percutaneous Coronary Intervention: A Meta-Analysis" Journal of Cardiovascular Development and Disease 9, no. 11: 406.
        https://doi.org/10.3390/jcdd9110406
    
    APA Style
    
                                Lv, F.,                                 Jiang, Y.,                                 Wang, Y.,                                 Zhang, T.,                                 & Zhou, Y.        
        
        (2022). AGTR1rs5186 Polymorphism Is Associated with the Risk of Restenosis after Percutaneous Coronary Intervention: A Meta-Analysis. Journal of Cardiovascular Development and Disease, 9(11), 406.
        https://doi.org/10.3390/jcdd9110406